Skip to main content
. Author manuscript; available in PMC: 2020 Jun 1.
Published in final edited form as: Depress Anxiety. 2019 Apr 8;36(6):565–575. doi: 10.1002/da.22892

Table 1:

Baseline participant characteristics by relative telomere length quartile at blood draw in 1989/1990

1st Quartile (n=2200) 2nd Quartile (n=2200) 3rd Quartile (n=2201) 4th Quartile (n=2200)
Age*, (SD) 59.1 (6.2) 58.6 (6.5) 58.0 (6.4) 57.5 (6.6)
MHI-5 score (SD) 78.0 (13.8) 78.9 (13.4) 77.7 (14.4) 78.4 (13.4)
Case status§, % 35 35 34 35
Pack-years of smoking, (SD) 12.5 (18.1) 12.1 (17.7) 12.0 (17.9) 11.8 (18.0)
Body mass index, (SD) 25.2 (4.8) 25.4 (4.8) 25.2 (4.7) 25.2 (4.6)
Antidepressant use, % 5 4 4 4
Alcohol intake, gm/wk (SD) 5.6 (9.7) 5.5 (9.6) 5.6 (9.9) 5.2 (8.8)
Physical activity, MET hrs/wk (SD) 16.9 (23.6) 16.9 (21.8) 17.1 (25.8) 16.1 (17.7)
Education: BA, % 20 21 19 22
Education: MA or DR, % 11 10 10 10
Pre-menopausal, % 14 14 14 13
Post-menopausal & currently on HRT, % 35 35 36 35
Paternal age-at-birth, (SD) 31.0 (6.9) 31.7 (7.2) 31.6 (7.1) 31.7 (6.9)
Hypertension, % 29 30 29 30
High cholesterol, % 42 43 44 44
CVD (MI, stroke, CABG) , % 7 5 6 5
Diabetes, % 4 5 4 4
Respiratory disease , % 9 9 8 7
Charlson Index, (SD) 0.2 (0.6) 0.2 (0.6) 0.2 (0.5) 0.2 (0.5)

Values are means (SD) or percentages and are standardized to the age distribution of the study population.

Value is not age- adjusted

Mental Health Inventory-5

§

Classified as a “case” in the nested case-control studies of various diseases used to form analytic sample

All comorbidities are from self-reports of diagnosis by a healthcare professional Charlson Comorbidity Index(Charlson et al., 1987)